ClinicalTrials.govpublic full text
Treatment of CD19 Chimeric Antigen Receptor T Cells for Pediatric Patients With CD19-positive B-cell Acute Lymphoblastic Leukemia Who Are Indicated for Hematopoietic Stem Cell Transplantation
very high risk acute lymphoblastic leukemia, cd19 car-t therapy, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 801495
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.